This article is from the source 'bbc' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.
You can find the current article at its original source at http://www.bbc.co.uk/news/world-europe-27490335
The article has changed 2 times. There is an RSS feed of changes available.
Previous version
1
Next version
Version 0 | Version 1 |
---|---|
UN warns of unprecedented growth in synthetic drugs | UN warns of unprecedented growth in synthetic drugs |
(1 day later) | |
Synthetic drugs such as methamphetamines and so-called "legal highs" are undergoing an "unprecedented global expansion", the UN has warned. | |
Nearly 350 new psychoactive substances (NPS) have been identified, the UN's Office on Drugs and Crime (UNODC) said. | Nearly 350 new psychoactive substances (NPS) have been identified, the UN's Office on Drugs and Crime (UNODC) said. |
Emergency services are struggling to treat users of the drugs, the office's latest World Drug Report warned. | Emergency services are struggling to treat users of the drugs, the office's latest World Drug Report warned. |
New methamphetamine supply routes and production centres in West Africa and Iran were also identified. | New methamphetamine supply routes and production centres in West Africa and Iran were also identified. |
The UN warned that the new NPS, or designer drugs, had gained popularity and were no longer restricted to niche markets. | The UN warned that the new NPS, or designer drugs, had gained popularity and were no longer restricted to niche markets. |
These drugs are not under any form of international controls and are often bought and sold online. They can often be as dangerous as more common drugs. | These drugs are not under any form of international controls and are often bought and sold online. They can often be as dangerous as more common drugs. |
Many legal highs are designed to mimic the effects of other drugs such as cannabis and ecstasy. | Many legal highs are designed to mimic the effects of other drugs such as cannabis and ecstasy. |
The number of types of synthetic cannabinoids rose from around 60 in the middle of 2012 to 110 last year. | The number of types of synthetic cannabinoids rose from around 60 in the middle of 2012 to 110 last year. |
New psychoactive substances | New psychoactive substances |
Despite the increase in the number of different synthetic drugs and warnings about their dangers, no new psychoactive substances have been added to a list of internationally controlled substances since 2009. | Despite the increase in the number of different synthetic drugs and warnings about their dangers, no new psychoactive substances have been added to a list of internationally controlled substances since 2009. |
The report said that it was too early to tell whether efforts to ban some substances by individual countries had led to a decline in long-term use of the drugs. | The report said that it was too early to tell whether efforts to ban some substances by individual countries had led to a decline in long-term use of the drugs. |
Treatment worries | Treatment worries |
The report also warned that many users buy new psychoactive drugs believing that they are more common substances such as ecstasy. | The report also warned that many users buy new psychoactive drugs believing that they are more common substances such as ecstasy. |
Users were also mixing different kinds of drug, making it more difficult to receive the correct treatment. | Users were also mixing different kinds of drug, making it more difficult to receive the correct treatment. |
The drugs themselves could also be tainted by other substances, causing further complications, the report warned. | The drugs themselves could also be tainted by other substances, causing further complications, the report warned. |
The UK became one of the only countries to ban a formerly "legal high" when it classified mephedrone as a class B drug in 2010. | The UK became one of the only countries to ban a formerly "legal high" when it classified mephedrone as a class B drug in 2010. |
Previous version
1
Next version